FDA 483 - BPL Plasma, Inc.

An inspection of BPL Plasma, Inc. in El Paso, Texas, revealed that the firm failed to provide complete test results for relevant transfusion-transmitted infections to deferred donors. Specifically, information letters lacked confirmatory or supplemental test results for conditions like syphilis, hepatitis B, anti-HCV, and HIV. This indicates deficiencies in donor counseling and the firm's standard operating procedures.